Influential factors in the adherence and abandonment of preventive therapy for latent tuberculosis infection in patients with HIV

被引：0
|
作者：
Bedoya Serna, Beatriz Eugenia [1 ]
机构：
[1] Corp Invest Biol, Medellin, Colombia
来源：
ARCHIVOS DE MEDICINA | 2019年 / 19卷 / 01期
关键词：
HIV; latent tuberculosis; chemoprevention; FAILURE; PREDICTORS; ADULTS; TRIAL;
D O I：
10.30554/archmed.19.1.2791.2019
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Objective: to describe the factors that influence the lack of adherence to the treatment of the latent tuberculosis infection. Materials and methods: retrospective and descriptive study in people living with the human immunodeficiency virus treated in a health institution of Medellin, Colombia. Results: 45% of patients presented adherence problems such as interruptions less than 30 days or loss of follow-up, the statistical significance (p < 0.05) was presented in the variables of adverse effects and adherence to antiretroviral treatment. Conclusion: adverse effects to treatment and adherence to antiretroviral therapy are associated with problems of adherence to preventive treatment of latent tuberculosis infection.
引用
收藏
页数：12
相关论文
共 50 条
  • [21] Active tuberculosis and Mycobacterium tuberculosis latent infection in patients with HIV/AIDS
    Gutierrez, E. B.
    Gomes, V.
    Picone, C. M.
    Suga, H.
    Atomiya, A. N.
    HIV MEDICINE, 2009, 10 (09) : 564 - 572
  • [22] Adherence to preventive treatment for latent tuberculosis infection in close contacts of pulmonary tuberculosis patients: A cluster-randomized controlled trial in China
    Chen, Hui
    Zhang, Hui
    Cheng, Jun
    Sun, Dingyong
    Wang, Qiaozhi
    Wu, Chengguo
    Liu, Yushu
    Xia, Yinyin
    Xu, Caihong
    Zhang, Canyou
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2024, 147
  • [23] Changing Concepts of "Latent Tuberculosis Infection" in Patients Living with HIV Infection
    Lawn, Stephen D.
    Wood, Robin
    Wilkinson, Robert J.
    CLINICAL & DEVELOPMENTAL IMMUNOLOGY, 2011,
  • [24] THE ADHERENCE AND ADVERSE EFFECT OF USING PREVENTIVE THERAPY FOR LATENT TUBERCULOSIS THERAPY AMONG KIDNEY TRANSPLANT CANDIDATES
    Shu, Chin-Chung
    Lee, Chin-Yuan
    Lin, Shu-Wen
    RESPIROLOGY, 2018, 23 : 60 - 61
  • [25] INCREASING ADHERENCE FOR LATENT TUBERCULOSIS INFECTION THERAPY WITH HEALTH DEPARTMENT-ADMINISTERED THERAPY
    Cruz, Andrea T.
    Starke, Jeffrey R.
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2012, 31 (02) : 193 - 195
  • [26] Effect of directly observed preventive therapy for latent tuberculosis infection in San Francisco
    White, MC
    Gournis, E
    Kawamura, M
    Menendez, E
    Tulsky, JP
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2003, 7 (01) : 30 - 35
  • [27] Toxicity and adherence to treatment for latent tuberculosis infection in patients with hematologic malignancies
    Sanchez-Garcia, E. M.
    Gamallo, R.
    Blanco-Moure, A.
    Viejo, M. A.
    Amador, L.
    Anibarro, L.
    INFECTION, 2013, 41 (05) : 903 - 907
  • [28] Toxicity and adherence to treatment for latent tuberculosis infection in patients with hematologic malignancies
    E. M. Sánchez-García
    R. Gamallo
    A. Blanco-Moure
    M. A. Viejo
    L. Amador
    L. Anibarro
    Infection, 2013, 41 : 903 - 907
  • [29] Screening for tuberculosis in adults with advanced HIV infection prior to preventive therapy
    Mohammed, A
    Ehrlich, R
    Wood, R
    Cilliers, F
    Maartens, G
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2004, 8 (06) : 792 - 795
  • [30] Factors associated with treatment adherence in a randomised trial of latent tuberculosis infection treatment
    Trajman, A.
    Long, R.
    Zylberberg, D.
    Dion, M. J.
    Al-Otaibi, B.
    Menzies, D.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2010, 14 (05) : 551 - 559
12345